C6orf115 Homolog (H. Sapiens) (C6orf115) Antikörper (Cy5)

Details zu Produkt Nr. ABIN1704812
Antigen
  • C6orf115
  • Costars
  • HSPC280
  • PRO2013
  • C9H6orf115
  • c6orf115
  • 1700028I04Rik
  • 3110003A17Rik
  • ABRA C-terminal like
  • ABRA C-terminal like L homeolog
  • ABRACL
  • abracl.L
  • Abracl
Reaktivität
Human, Maus, Ratte (Rattus)
17
14
14
Wirt
Kaninchen
14
3
Klonalität
Polyklonal
Konjugat
Cy5
1
1
1
1
1
1
1
1
1
1
1
1
1
Applikation
Immunofluorescence (Paraffin-embedded Sections) (IF (p))
12
6
3
3
Optionen
Immunogen KLH conjugated synthetic peptide derived from human C6orf115
Isotyp IgG
Reinigung Purified by Protein A.
Antigen
Andere Bezeichnung C6orf115
Hintergrund

C6orf115 is a Making up nearly 6 % of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6. The C6orf115 gene product has been provisionally designated C6orf115 pending further characterization.

Synonyms: ABRA C-terminal-like protein, abracl, ABRAL_HUMAN, Chromosome 6 open reading frame 115, Costars family protein ABRACL, HSPC280, Hypothetical protein LOC58527, PRO2013, Uncharacterized protein C6orf115.

Gen-ID 58527
Applikations-hinweise IF(IHC-P) 1:50-200
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Konzentration 1 μg/μL
Buffer Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
Lagerung 4 °C
Informationen zur Lagerung Store at 4°C
Haltbarkeit 12 months
Haben Sie etwas anderes gesucht?